Cargando…

1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada

BACKGROUND: Cefazolin (CZ) is a 1(st)-line therapy for methicillin-susceptible Staphylococcus aureus (MSSA) infections due to its tolerability, lower toxicity, and convenient dosing. However, some strains exhibit reduced susceptibility to CZ when present in high inoculum. Treatment failure and worse...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Kristine, Waddell, Barbara Jean M, Ligier, Chloe, Svishchuk, Julianna, Kipp, Alexander, Lam, John, Robinson, Stephen, Somayaji, Ranjani, Conly, John M, Gregson, Daniel, Parkins, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752948/
http://dx.doi.org/10.1093/ofid/ofac492.1443
_version_ 1784850854529990656
author Du, Kristine
Waddell, Barbara Jean M
Ligier, Chloe
Svishchuk, Julianna
Kipp, Alexander
Lam, John
Robinson, Stephen
Somayaji, Ranjani
Conly, John M
Gregson, Daniel
Parkins, Michael
author_facet Du, Kristine
Waddell, Barbara Jean M
Ligier, Chloe
Svishchuk, Julianna
Kipp, Alexander
Lam, John
Robinson, Stephen
Somayaji, Ranjani
Conly, John M
Gregson, Daniel
Parkins, Michael
author_sort Du, Kristine
collection PubMed
description BACKGROUND: Cefazolin (CZ) is a 1(st)-line therapy for methicillin-susceptible Staphylococcus aureus (MSSA) infections due to its tolerability, lower toxicity, and convenient dosing. However, some strains exhibit reduced susceptibility to CZ when present in high inoculum. Treatment failure and worsened outcomes are documented in BSI cohorts treated with CZ when infections are caused by strains demonstrating this inoculum effect (IE) (Miller, 2018). The objective of our study was to investigate the incidence of MSSA strains demonstrating IE over time across a general population, free of referral bias. METHODS: All initial isolates of first episodes of MSSA BSI from persons in Calgary, Canada were analyzed during 2012-14 and 2019. CZ minimum inhibitory concentration (MIC) was determined at standard (SI: 5x10(5) CFU/mL) and high inocula (HI: 5x10(7) CFU/mL) using the broth microdilution method at 24 hours as per 2009 CLSI criteria. Isolates were defined as having the CZ IE if they had a ≥ 4-fold difference between MIC at SI and HI. Isolates were defined as having a pronounced IE (pIE), if they were susceptible at SI but resistant at HI with an MIC ≥ 32µg/mL. Population density of Calgary was obtained from census data. Annual incidence rates (IR) were calculated by dividing the number of IE and pIE by the mid-year population data, and IR ratios (IRR) were calculated for IE and pIE by comparing 2019 to 2012 rates. RESULTS: During the years of study, 1040 individuals experienced at least one episode of MSSA BSI. The mean incidence rates of IE and pIE were 6.50 and 0.98 per 100,000 person-years, respectively. Comparing 2019 to 2012, rates of IE decreased significantly with an IRR of 0.67 (95% CI 0.47 – 0.95) but rates of pIE were not significantly different (IRR 1.24; 95% CI 0.43 – 3.86). Incidence rates of IE and pIE in Calgary, Canada in 2012-14 and 2019. [Figure: see text] MSSA BSIs in Calgary, Canada over the years are shown alongside corresponding rates of IE and pIE. The population density was used to find rates for IE/pIE per 100,000 person-years. CONCLUSION: Population-based studies on MSSA BSI with the IE and pIE phenotype are lacking. Herein, we observed that while the incidence of MSSA with pIE has not changed, those occurring with the IE have decreased. Further studies on the clinical implications of pIE are needed. DISCLOSURES: All Authors: No reported disclosures.
format Online
Article
Text
id pubmed-9752948
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97529482022-12-16 1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada Du, Kristine Waddell, Barbara Jean M Ligier, Chloe Svishchuk, Julianna Kipp, Alexander Lam, John Robinson, Stephen Somayaji, Ranjani Conly, John M Gregson, Daniel Parkins, Michael Open Forum Infect Dis Abstracts BACKGROUND: Cefazolin (CZ) is a 1(st)-line therapy for methicillin-susceptible Staphylococcus aureus (MSSA) infections due to its tolerability, lower toxicity, and convenient dosing. However, some strains exhibit reduced susceptibility to CZ when present in high inoculum. Treatment failure and worsened outcomes are documented in BSI cohorts treated with CZ when infections are caused by strains demonstrating this inoculum effect (IE) (Miller, 2018). The objective of our study was to investigate the incidence of MSSA strains demonstrating IE over time across a general population, free of referral bias. METHODS: All initial isolates of first episodes of MSSA BSI from persons in Calgary, Canada were analyzed during 2012-14 and 2019. CZ minimum inhibitory concentration (MIC) was determined at standard (SI: 5x10(5) CFU/mL) and high inocula (HI: 5x10(7) CFU/mL) using the broth microdilution method at 24 hours as per 2009 CLSI criteria. Isolates were defined as having the CZ IE if they had a ≥ 4-fold difference between MIC at SI and HI. Isolates were defined as having a pronounced IE (pIE), if they were susceptible at SI but resistant at HI with an MIC ≥ 32µg/mL. Population density of Calgary was obtained from census data. Annual incidence rates (IR) were calculated by dividing the number of IE and pIE by the mid-year population data, and IR ratios (IRR) were calculated for IE and pIE by comparing 2019 to 2012 rates. RESULTS: During the years of study, 1040 individuals experienced at least one episode of MSSA BSI. The mean incidence rates of IE and pIE were 6.50 and 0.98 per 100,000 person-years, respectively. Comparing 2019 to 2012, rates of IE decreased significantly with an IRR of 0.67 (95% CI 0.47 – 0.95) but rates of pIE were not significantly different (IRR 1.24; 95% CI 0.43 – 3.86). Incidence rates of IE and pIE in Calgary, Canada in 2012-14 and 2019. [Figure: see text] MSSA BSIs in Calgary, Canada over the years are shown alongside corresponding rates of IE and pIE. The population density was used to find rates for IE/pIE per 100,000 person-years. CONCLUSION: Population-based studies on MSSA BSI with the IE and pIE phenotype are lacking. Herein, we observed that while the incidence of MSSA with pIE has not changed, those occurring with the IE have decreased. Further studies on the clinical implications of pIE are needed. DISCLOSURES: All Authors: No reported disclosures. Oxford University Press 2022-12-15 /pmc/articles/PMC9752948/ http://dx.doi.org/10.1093/ofid/ofac492.1443 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Du, Kristine
Waddell, Barbara Jean M
Ligier, Chloe
Svishchuk, Julianna
Kipp, Alexander
Lam, John
Robinson, Stephen
Somayaji, Ranjani
Conly, John M
Gregson, Daniel
Parkins, Michael
1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada
title 1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada
title_full 1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada
title_fullStr 1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada
title_full_unstemmed 1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada
title_short 1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada
title_sort 1813. a population-based multi-year assessment of the incidence of high inoculum cefazolin (cz) resistance amongst methicillin-susceptible staphylococcus aureus (mssa) causing bloodstream infections (bsis) over time in calgary, canada
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752948/
http://dx.doi.org/10.1093/ofid/ofac492.1443
work_keys_str_mv AT dukristine 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT waddellbarbarajeanm 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT ligierchloe 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT svishchukjulianna 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT kippalexander 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT lamjohn 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT robinsonstephen 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT somayajiranjani 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT conlyjohnm 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT gregsondaniel 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada
AT parkinsmichael 1813apopulationbasedmultiyearassessmentoftheincidenceofhighinoculumcefazolinczresistanceamongstmethicillinsusceptiblestaphylococcusaureusmssacausingbloodstreaminfectionsbsisovertimeincalgarycanada